欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
GS-441524_1191237-69-0_产品详情
1191237-69-0
  • names:

    CID 44468216

  • CAS号:

    1191237-69-0

    MDL Number:
  • MF(分子式): C12H13N5O4 MW(分子量): 291.263
  • EINECS: Reaxys Number:
  • Pubchem ID:44468216 Brand:BIOFOUNT
GS-441524
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名 GS441524;瑞德西韦中间体;瑞德西韦杂质;GS-441524;EVO-984;EVO 984;gs441524瑞德西韦
英文别名 GS-441524;(2R,3S,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxyméthyl)tétrahydro-2-furanecarbonitrile (non-preferred name)GS 441524;(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile
CAS号 1191237-69-0
Inchi InChI=1S/C12H13N5O4/c13-4-12(10(20)9(19)7(3-18)21-12)8-2-1-6-11(14)15-5-16-17(6)8/h1-2,5,7,9-10,18-20H,3H2,(H2,14,15,16)/t7-,9-,10-,12+/m1/s1
InchiKey BRDWIEOJOWJCLU-LTGWCKQJSA-N
分子式 Formula C12H13N5O4
分子量 Molecular Weight 291.263
溶解度Solubility
性状 white power
储藏条件 Storage conditions Store at room temp;常温阴凉干燥处存储
GS-441524与瑞德西韦相比较,研究发现GS-441524不能很好地进入细胞。
GS-441524 has been found to transport poorly into cells compared to remdesivir.
GS-441524 is phosphorylated 3 times to form the active nucleoside triphosphate。
GS-441524被三磷酸活化后,可以形成“GS-441524三磷酸腺”(GS-443902|1355149-45-9),目前已经被应用于抑制新型冠状病毒的研究中,实验证明GS-443902可以终止新型冠状病毒的复制。
GS-441524合成制备的工艺说明:
制备方法:将1.50g(I-1)的核苷化合物加入圆底烧瓶中,将200mL四氢呋喃和2.47g(F)的活性磷酸酯在冰浴中冷却至0℃ 在搅拌下缓慢加入10mL的叔丁基氯化镁溶液(1.0M四氢呋喃溶液)。滴加完成后,将温度升至40℃,并使反应进行2小时。 反应后,将反应溶液在减压下浓缩,将浓缩物加入到200mL二氯甲烷中,并用50mL饱和氯化钠溶液洗涤两次。有机相用无水硫酸钠干燥并在减压下浓缩。 通过硅胶柱色谱法使用乙酸乙酯/石油醚= 1/1的混合物作为洗脱剂分离浓缩的残余物,获得1.58g(I-6)的化合物,并且计算的产率为52%。
步骤1:(2R,3R,4S,5R)-2-(4-氨基吡咯并[1,2-f] [1,2,4]三嗪-7-基)-3,4-二羟基-5-( 羟甲基)四氢呋喃-2-腈与叔丁基氯化镁在四氢呋喃中于20℃加热; 持续0.5h; 冰冷却;
步骤2:四氢呋喃中于20℃的环戊基((全氟苯氧基)(苯氧基)磷酰基)-L-丙氨酸盐; 持续24小时。
Bioactivity|In vitro: Efficacy|Quantitative Results
pX Parameter Value (qual) Value (quant) Unit Cell Dose Effect
7.28 inhibition rate   100   CRFK cell line 1 μM Anticytopathic
6.74 EC50(viral titre reduction)   0.18 μM airway epithelium cell   antiviral agent
6.66 IC50   0.22 µM HAEC cell line   antiviral agent
6.32 EC50(Virus-induced cytopathic effect) = 0.48 µM HEp-2 cell line   antiviral agent
6 IC50   1000 nM HeLa cell line   antifungal agent
5.77 EC50(Virus replication) = 1.71 μM Vero cell line   antiviral agent
5.28 IC90 > 47 μM Vero cell line 0.047 – 47 μM Anticytopathic
4.55 EC50(Virus replication) = 27.9 μM MDCK cell line   antiviral agent
1 CC50 (cytotoxic concentration)(Cell growth) > 89 μM Huh-7 cell line   Cytotoxic
产品说明 GS-441524(GS 441524)是一种腺苷核苷酸类似物抗病毒药,类似于瑞德西韦,GS-441524也是合成瑞德西韦的中间体。
IntroductionGS-441524 is an adenosine nucleotide analog antiviral, similar to remdesivir.
Application1GS-441524是合成潜在冠状病毒药物瑞德细韦的中间体。
Application2GS-441524是瑞德西韦的杂质。
Application3
GS-441524 is an adenosine nucleotide analog antiviral, similar to remdesivir. This molecule was patented in 2009. In vitro studies of GS-441524 have determined it has a higher EC50 than remdesivir. GS-441524 continues to be studied in the treatment of Feline Infectious Peritonitis Virus, a coronavirus that only infects cats.

 
警示图
危险性
危险性警示 Not available
安全声明 H226,H315,H319,H335
安全防护 P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362
备注
GS-441524 is an adenosine nucleotide analog antiviral, similar to remdesivir. This molecule was patented in 2009. In vitro studies of GS-441524 have determined it has a higher EC50 than remdesivir. GS
GS-441524 is an adenosine nucleotide analog antiviral, similar to remdesivir.

GS441524的参考文献:
GS-441524 is an adenosine nucleotide analog antiviral, similar to remdesivir. This molecule was patented in 2009. In vitro studies of GS-441524 have determined it has a higher EC50 than remdesivir. GS-441524 continues to be studied in the treatment of Feline Infectious Peritonitis Virus, a coronavirus that only infects cats。
Murphy BG, Perron M, Murakami E, Bauer K, Park Y, Eckstrand C, Liepnieks M, Pedersen NC: The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Vet Microbiol. 2018 Jun;219:226-233. doi: 10.1016/j.vetmic.2018.04.026. Epub 2018 Apr 22. [PMID:29778200]
Amirian ES, Levy JK: Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses. One Health. 2020 Mar 27;9:100128. doi: 10.1016/j.onehlt.2020.100128. eCollection 2020 Jun. [PMID:32258351]
Lo MK, Jordan R, Arvey A, Sudhamsu J, Shrivastava-Ranjan P, Hotard AL, Flint M, McMullan LK, Siegel D, Clarke MO, Mackman RL, Hui HC, Perron M, Ray AS, Cihlar T, Nichol ST, Spiropoulou CF: GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses. Sci Rep. 2017 Mar 6;7:43395. doi: 10.1038/srep43395. [PMID:28262699]
de Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, Scott D, Cihlar T, Feldmann H: Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci U S A. 2020 Feb 13. pii: 1922083117. doi: 10.1073/pnas.1922083117. [PMID:32054787]
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents